PROFORTIL  is the only formulation that has 9 clinical studies demonstrating its efficacy and safety.

PROFORTIL has proven pregnancy rates of 25.8% – 41.3%.

In a controlled study of 205 patients, for example, PROFORTIL was superior to the control group in improving all key metrics for sperm quality – ejaculatory volume, cell density, motility and morphology.

PROFORTIL reduces DNA breaks, which decreases the likelihood of miscarriages

In a separate study, PROFORTIL was given to male patients with subclinical varicocele. Post-treatment evaluation showed an improvement in all male fertility parameters, with pregnancy occurring in 41% of couples.

PROFORTIL is made in Austria with European-sourced ingredients and produced in compliance with Pharmaceutical Good Manufacturing Practices.